A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1998
11/12/1998	WO1998050382A1 Amidine derivatives as inhibitors of nitric oxide synthase
11/12/1998	WO1998050381A1 3-(pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
11/12/1998	WO1998050380A1 Compounds
11/12/1998	WO1998050372A1 Substituted heterocycles and their use in medicaments
11/12/1998	WO1998050370A1 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds
11/12/1998	WO1998050368A1 Benzimidazole derivative
11/12/1998	WO1998050367A1 Processes and intermediates for preparing substituted indazole derivatives
11/12/1998	WO1998050365A1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
11/12/1998	WO1998050364A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/12/1998	WO1998050363A1 Substituted tetrahydro isoquinolines as modulators of dopamine d3 receptors
11/12/1998	WO1998050358A1 Indole derivatives having combined 5ht1a, 5ht1b and 5ht1d receptor antagonist activity
11/12/1998	WO1998050356A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	WO1998050353A1 Vitamin d3 derivatives and process for producing the same
11/12/1998	WO1998050351A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
11/12/1998	WO1998050344A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
11/12/1998	WO1998050342A1 Protease inhibitors
11/12/1998	WO1998050075A1 Cox-2 inhibitors in combination with nmda-blockers for treating pain
11/12/1998	WO1998050074A2 Compositions of antichlamydial agents for the diagnosis and management of infection caused by chlamydia
11/12/1998	WO1998050073A1 Integrin ligand, human mindin
11/12/1998	WO1998050064A2 Adhesion prevention and an endoscopic insufflation system therefor
11/12/1998	WO1998050063A1 Method of treating hyperprolactinemia and prolactinomas
11/12/1998	WO1998050062A1 Compositions and methods of therapy for igf-i-responsive conditions
11/12/1998	WO1998050059A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998	WO1998050058A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998	WO1998050054A1 Plant extracts for the treatment of increase bone resorption
11/12/1998	WO1998050052A1 Novel use of phospholipids of animal origin in therapy and/or dietetics
11/12/1998	WO1998050051A1 Treatment of sickle cell disease, treatment of immune system diseases and other diseases normally associated with sickle cell anemia
11/12/1998	WO1998050050A1 Covalently linked n,o-carboxymethylchitosan and uses thereof
11/12/1998	WO1998050048A1 Aplidine as an l-type calcium channel enhancer
11/12/1998	WO1998050047A1 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
11/12/1998	WO1998050046A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998	WO1998050045A1 Improvements in or relating to long-acting antimicrobials
11/12/1998	WO1998050044A1 Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
11/12/1998	WO1998050043A1 Novel therapy for constipation
11/12/1998	WO1998050042A1 Pregnan-3-ol-20-ones
11/12/1998	WO1998050039A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure erectile dysfunction
11/12/1998	WO1998050038A1 Use of quinazoline compounds for the treatment of polycystic kidney disease
11/12/1998	WO1998050037A1 Anxiolytics
11/12/1998	WO1998050036A1 Endocrine modulation with positive modulators of ampa type glutamate receptors
11/12/1998	WO1998050035A1 Pharmaceutical compositions of tizoxanide and nitazoxanide
11/12/1998	WO1998050033A1 Cox-2 selective carprofen for treating pain and inflammation in dogs
11/12/1998	WO1998050032A1 BETA-LACTAM INHIBITORS OF CoA-IT
11/12/1998	WO1998050031A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050030A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050029A1 Inhibitors of protein isoprenyl transferases
11/12/1998	WO1998050028A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/12/1998	WO1998050027A1 Method of improving disturbed behavior and elevating mood in humans
11/12/1998	WO1998050026A1 Treatment or prevention of menopausal symptoms and osteoporosis
11/12/1998	WO1998050025A1 Preventives/remedies for arteriosclerosis
11/12/1998	WO1998050024A1 8-iso-prostaglandins for glaucoma therapy
11/12/1998	WO1998050023A1 Use of high dose retinoids for the treatment of skin disorders
11/12/1998	WO1998050021A1 Inhibition of lfa-1/icam-2 dependent leukemic cell aggregation
11/12/1998	WO1998050020A1 Composition and method for treatment of helicobacter pylori infection
11/12/1998	WO1998050019A1 Stable oral pharmaceutical dosage forms
11/12/1998	WO1998050018A1 Drug delivery system
11/12/1998	WO1998050017A1 Poly(vinyl alcohol) cryogel
11/12/1998	WO1998050016A2 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
11/12/1998	WO1998050014A1 Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
11/12/1998	WO1998050013A1 Use of oligosaccharides for the treatment of connective tissues
11/12/1998	WO1998050004A1 Ascorbyl-phosphoryl-cholesterol
11/12/1998	WO1998049970A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis
11/12/1998	WO1998049906A1 Peri-operative drink
11/12/1998	WO1998049897A1 Beta lactams as antiproliferative agents
11/12/1998	WO1998049896A1 A method of treating vasomotor symptoms
11/12/1998	WO1998049895A1 Selectively cytotoxic acetogenin compounds
11/12/1998	WO1998035951A3 New aminopiperazine derivatives
11/12/1998	WO1998032428A3 Compositions comprising choline and use of choline to treat endotoxic shock
11/12/1998	WO1997039128A3 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
11/12/1998	DE19720767A1 Use of e.g. p-hydroxybenzoic acid, gallic acid, vanillic acid, syringic acid, myricetin, quercetin and camphor oil
11/12/1998	DE19719585A1 New N-sulphonyl-di:amino:carboxylic acid derivatives
11/12/1998	CA2299455A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998	CA2289731A1 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
11/12/1998	CA2289705A1 Beta lactams as antiproliferative agents
11/12/1998	CA2289676A1 Prophylactic/therapeutic agents for atherosclerosis
11/12/1998	CA2289602A1 Protease inhibitors
11/12/1998	CA2289548A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998	CA2289228A1 Diagnosis and management of infection caused by chlamydia
11/12/1998	CA2289190A1 Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
11/12/1998	CA2289124A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998	CA2289115A1 Recombinant antibody-enzyme fusion proteins
11/12/1998	CA2289108A1 Salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity
11/12/1998	CA2289102A1 2-indolinone derivatives as modulators of protein kinase activity
11/12/1998	CA2289099A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
11/12/1998	CA2289096A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alpha-diol-20-one 3-sulfate useful as progestins and cns disorders
11/12/1998	CA2289095A1 Pregnane 3,20 diol mono- and di-sulphates
11/12/1998	CA2289094A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them
11/12/1998	CA2289025A1 Human serine protease precursor
11/12/1998	CA2289011A1 B-ring estratriene diol sulphates
11/12/1998	CA2289010A1 Protease inhibitors
11/12/1998	CA2289008A1 Estrenes
11/12/1998	CA2289006A1 Pregnan-3-ol-20-ones
11/12/1998	CA2289001A1 Novel heterocyclic compounds
11/12/1998	CA2288999A1 B-ring estratrienes
11/12/1998	CA2288986A1 Beta-lactam inhibitors of coa-it
11/12/1998	CA2288946A1 Modified antisense nucleotides complementary to a section of the human ha-ras gene
11/12/1998	CA2288901A1 Uncoupling protein homologue: ucp 3
11/12/1998	CA2288899A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/12/1998	CA2288876A1 Drug delivery system
11/12/1998	CA2288868A1 Protease inhibitors
11/12/1998	CA2288778A1 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds

1 ... 6581 6582 6583 6584 6585 6586 6587 6588 6589 6590 6591 6592 6593 6594 6595 6596 6597 6598 6599 6600 6601 ... 7860